bims-mistre Biomed News
on Mito stress
Issue of 2026–08–16
nineteen papers selected by
Ellen Siobhan Mitchell, MitoQ



  1. Int Rev Neurobiol. 2026 ;pii: S0074-7742(26)00038-3. [Epub ahead of print]188 1-32
      Alzheimer's disease (AD) is increasingly recognized as a disorder marked not only by amyloid-β and tau pathology, but also by profound disturbances in brain energy metabolism that arise early in disease progression. Accumulating evidence indicates that impairments in glucose utilization, insulin signaling, and mitochondrial function precede neurodegeneration and contribute directly to synaptic failure and cognitive decline. This chapter presents a comprehensive overview of Alzheimer's disease through the lens of metabolic dysfunction, highlighting disrupted neuronal bioenergetics as a central and unifying feature of pathogenesis. We examine key metabolic pathways implicated in AD, including cerebral glucose hypometabolism, brain insulin resistance, impaired glycolysis, mitochondrial oxidative phosphorylation deficits, oxidative stress, and altered mitochondrial dynamics. The chapter further discusses therapeutic strategies aimed at restoring metabolic homeostasis, such as insulin sensitization, enhancement of glucose transport, activation of mitochondrial biogenesis, modulation of the electron transport chain, and the use of mitochondria-targeted antioxidants. In parallel, alternative energy approaches-including ketone metabolism, fatty acid oxidation, and pentose phosphate pathway activation-are explored as promising avenues to bypass glucose-dependent energy deficits and reinforce neuronal resilience. Emerging directions in metabolic therapeutics are also highlighted, including combination treatment strategies, NAD+-sirtuin and AMPK signaling, and the expanding role of the gut microbiome-brain metabolism axis. By integrating insights from experimental models, neuroimaging studies, and clinical trials, this chapter underscores the potential of metabolic interventions to enable early, disease-modifying strategies for Alzheimer's disease.
    Keywords:  Alzheimer’s disease; Glucose hypometabolism; Metabolic hypothesis; Metabolic targets; Mitochondria targeted therapy; Neurodegeneration
    DOI:  https://doi.org/10.1016/bs.irn.2026.05.010
  2. Drug Des Devel Ther. 2026 ;20 639156
       Introduction: Nicotinamide adenine dinucleotide (NAD+) is vital for maintaining normal cellular function. Aging-associated NAD+ decline is linked to the onset and progression of age-related diseases. Consequently, oral supplementation of NAD+ precursors has been shown to improve disease-relevant phenotypes and physiological outcomes in model organisms. Among NAD+ precursors, nicotinamide riboside (NR) has attracted interest owing to its potent in vivo NAD+ biosynthetic activity. However, NR exhibits poor stability in the circulatory system. Thus, there is considerable interest in discovering effective NAD+ precursor forms that can address these limitations. Here, we report Restorin NR, a proprietary crystalline form of NR fumarate, as a novel NAD+ enhancer.
    Methods: The current study was performed to compare the effectiveness of three different NAD+ precursors, including nicotinamide mononucleotide (NMN), NR chloride, and Restorin NR in boosting NAD+ levels in an aged murine model.
    Results: The results showed that Restorin NR significantly increased NAD+ levels above equivalent doses of NMN or NR chloride. Notably, Restorin NR at the low dose of 0.33 mmol/kg/day induced blood NAD+ elevation statistically equivalent to that of a higher dose of NR chloride or NMN (1 mmol/kg/day, n=11). At the matched dose of 1 mmol/kg/day, Restorin NR yielded significantly higher circulating NAD+ levels than either comparison treatment. These results confirm Restorin NR's superiority to the tested precursors for NAD+ concentrations in circulation.
    Discussion: Overall, our research identifies a new crystalline salt form of NR and classifies Restorin NR as a promising new therapeutic agent to enhance NAD+ levels and combat aging.
    Keywords:  NAD⁺ precursor; NMN; Restorin NR; nicotinamide mononucleotide; nicotinamide riboside chloride; nicotinamide riboside fumarate
    DOI:  https://doi.org/10.2147/DDDT.S639156
  3. Front Aging. 2026 ;7 1876149
      Because of population aging and morbidity expansion, extending healthspan has become a global challenge and it is required to elucidate molecular mechanisms underlying aging and age-related diseases. Mitochondrial dysfunction is a hallmark of aging, characterized by impaired oxidative phosphorylation, increased production of reactive oxygen species (ROS), and metabolic imbalance. Therefore, maintaining mitochondrial homeostasis is essential for healthspan. Mitochondrial respiratory chain complexes organize into higher-order assemblies known as supercomplexes (SCs), which enable to efficient energy or ATP production with repressed ROS generation. Notably, the assembly and stability of these SCs likely decline in aged mammals. In addition, factors such as COX7RP/SCAF1 and mitochondrial lipid cardiolipin have emerged as key regulators of SC assembly. In this review, we summarize the molecular assembly, physiological roles, and longevity implications of SC in healthy mammals. We further discuss emerging evidence supporting SC modulation as a potential strategy for promoting healthy aging.
    Keywords:  OXPHOS; lifespan; longevity; mitochondria; supercomplex
    DOI:  https://doi.org/10.3389/fragi.2026.1876149
  4. Cells. 2026 Aug 03. pii: 1404. [Epub ahead of print]15(15):
      Aging is accompanied by a progressive decline in mitochondrial quality, bioenergetic flexibility, and stress resilience. Aging mitochondria are increasingly recognized as active inflammatory signaling platforms rather than passive targets of cellular damage. Excess mtROS, leaked mtDNA, defective mitophagy, altered NAD+ metabolism, and impaired pyruvate oxidation together create a cellular environment that favors persistent inflammatory activation. These signals engage NF-κB, NLRP3 inflammasome, cGAS-STING, and SASP pathways, allowing mitochondrial stress to spread from organelle dysfunction to tissue-level inflammation. Within this framework, pyruvate dehydrogenase kinase 4 (PDK4) is of particular interest because it directly controls mitochondrial pyruvate entry through inhibition of the pyruvate dehydrogenase complex. By phosphorylating and inhibiting the pyruvate dehydrogenase complex, PDK4 limits mitochondrial pyruvate oxidation and favors lactate accumulation, fatty acid utilization, and redox-inflammatory signaling. Recent work in senescent cells links PDK4-dependent lactate accumulation to NOX1-derived ROS and SASP activity, suggesting a direct route by which altered fuel handling may reinforce inflammation. Here, we review mitochondrial dysfunction as the organizing principle of age-associated meta-inflammation, discuss PDK4 as a central metabolic checkpoint, examine tissue-specific consequences in muscle, adipose tissue, brain, and kidney, and evaluate therapeutic strategies aimed at restoring mitochondrial function to suppress chronic inflammation and preserve healthspan.
    Keywords:  NLRP3; PDK4; SASP; aging; inflammaging; meta-inflammation; mitochondrial dysfunction; mitophagy; mtROS; pyruvate dehydrogenase
    DOI:  https://doi.org/10.3390/cells15151404
  5. J Steroid Biochem Mol Biol. 2026 Aug 11. pii: S0960-0760(26)00168-8. [Epub ahead of print]265 107102
      Menopause is a universal physiological transition marked by the permanent cessation of ovarian estrogen secretion, with far-reaching consequences for cardiometabolic health. Among these consequences, lipid dysregulation stands as one of the most clinically significant, substantially elevating the risk of cardiovascular disease and metabolic syndrome in postmenopausal women. Estrogen deficiency disrupts hepatic lipid metabolism, alters lipoprotein particle composition, promotes visceral adiposity, and triggers a chronic low-grade inflammatory state, collectively establishing an atherogenic lipid profile. Although the broad association between menopause and dyslipidemia has long been recognized, the precise cellular and molecular mechanisms underlying this relationship remain incompletely characterized. This review synthesizes current evidence on the pathophysiological mechanisms linking estrogen deficiency to lipid dysregulation in menopause, encompassing alterations in LDL and HDL metabolism, triglyceride accumulation, changes in lipoprotein lipase (LPL) activity, hepatic lipid accumulation, and the roles of estrogen receptor signaling in adipose tissue and liver. Current and emerging therapeutic strategies are also discussed, including hormone replacement therapy (HRT), lifestyle modifications, lipid-lowering pharmacotherapy, and novel molecular targets. Advancing the mechanistic understanding of these processes is essential to developing precision therapeutic approaches that effectively address the heightened cardiometabolic risk in postmenopausal women.
    Keywords:  Cardiovascular risk; Dyslipidemia; Estrogen deficiency; Hormone replacement therapy; Lipid metabolism; Menopause; Metabolic syndrome
    DOI:  https://doi.org/10.1016/j.jsbmb.2026.107102
  6. Biology (Basel). 2026 Aug 06. pii: 1328. [Epub ahead of print]15(15):
      Cellular senescence is a root cause of aging and age-related disease. Senescent cells persist in tissues, secreting inflammatory factors that fuel inflammaging and immune decline. At the subcellular level, mitochondrial dysfunction has become recognized as a central driver of the senescent state: metabolism shifts toward glycolysis, mitophagy stalls while reactive oxygen species production escalates, mitochondrial dynamics tip toward hyperfusion or fragmentation, and damaged mitochondrial DNA leaks into the cytosol to activate the cyclic GMP-AMP synthase-stimulator of interferon genes pathway, amplifying the senescence-associated secretory phenotype. Conventional drugs have struggled to address these layered defects, steering interest toward natural bioactive compounds-polyphenols, flavonoids, saponins-that can simultaneously restore mitophagic flux, boost antioxidant defenses, rebalance fission-fusion, and intercept mitochondrial DNA-driven inflammation. However, the key issue is delivery: these molecules rarely reach mitochondria in meaningful concentrations in vivo due to their poor bioavailability, rapid metabolism, and off-target distribution. Platforms using triphenylphosphonium, mitochondria-penetrating peptides, or biomimetic shells have successfully funneled therapeutic payloads into mitochondria in several models of disease. We contend that the proposed systematic integration of these delivery systems with natural senotherapeutic compounds offers a promising direction for future research.
    Keywords:  cellular senescence; mitochondria-targeted delivery; mitochondrial dysfunction; natural bioactive compounds
    DOI:  https://doi.org/10.3390/biology15151328
  7. J Neuroimmune Pharmacol. 2026 Aug 12. pii: 38. [Epub ahead of print]21(1):
      The cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway is an essential cytosolic DNA-sensing system that plays an important role in the regulation of innate immune and inflammatory responses in the central nervous system (CNS). It was first discovered as a promising antiviral defense cascade and has since been shown to execute broader functions in neuroinflammation and neurodegeneration. The pathway can become hyperactive with the release of endogenous DNA from damaged nuclei, mitochondria, or genomic instability, leading to chronic production of type I interferon (TI-IFN), various pro-inflammatory cytokines, and eventually contributing to chronic neuroinflammatory diseases. Recent studies have found that dysregulated cGAS-STING signaling is associated with several neurological disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), traumatic brain injury (TBI), stroke, and age-related neurodegeneration. In the CNS, chronic activation of this pathway leads to activation of microglia, oxidative stress, breakdown of the blood-brain barrier (BBB), impaired function of the synapses, and neuronal death. Mitochondrial dysfunction and cytosolic release of mitochondrial DNA (mtDNA) further promote inflammatory signaling, thus perpetuating neurodegeneration. This review highlights the molecular and pathological mechanisms of cGAS-STING signaling in a broader aspect of neurological disorders and appraises the novel therapeutics already under development to inhibit this pathway to regulate neuroinflammation and enhance neurological outcomes.
    Keywords:  IRF3; NF-κB; Neurological diseases; STING inhibitors; Signaling pathways; cGAS-STING
    DOI:  https://doi.org/10.1007/s11481-026-10307-9
  8. Prog Neuropsychopharmacol Biol Psychiatry. 2026 Aug 09. pii: S0278-5846(26)00284-8. [Epub ahead of print]149 111886
       BACKGROUND: Growth differentiation factor 15 (GDF15) is a stress-responsive cytokine involved in metabolic and inflammatory pathways. We examined the associations of plasma GDF15 with incident brain disorders and explored potential mediating pathways and causality.
    METHODS: UK Biobank participants were followed for a median of 14 years. Plasma GDF15 was measured at baseline. Cox proportional hazards models assessed associations with incident brain disorders, including all-cause dementia (ACD), Alzheimer's disease (AD), Parkinson's disease (PD), anxiety, depression, sleep disorders, stroke, and epilepsy. Mediation analyses evaluated biochemical and hematological pathways, and one-sample Mendelian randomization (MR) was used to assess potential causal effects.
    RESULTS: Higher GDF15 levels were associated with increased risks of overall brain disorders and all examined subtypes. In continuous analyses (per 1-unit increase in log2-transformed GDF15), hazard ratios (95% CIs) were 1.54 (1.48-1.60) for overall brain disorders, 1.98 (1.80-2.17) for ACD, 1.84 (1.60-2.10) for AD, 1.37 (1.18-1.59) for PD, 1.26 (1.16-1.37) for anxiety, 1.38 (1.29-1.49) for depression, 1.40 (1.26-1.55) for sleep disorders, 1.92 (1.81-2.05) for stroke, and 1.71 (1.46-2.01) for epilepsy (all P < 0.001). Lipid- and inflammation-related markers appeared to partially mediate these associations. High-density lipoprotein cholesterol (HDL-C) accounted for an estimated 7.51% of the association with depression and 11.47% with sleep disorders, while neutrophil count showed relatively larger mediation estimates across multiple outcomes. MR analyses did not support a direct causal effect of GDF15.
    CONCLUSION: Plasma GDF15 is associated with a broad range of incident brain disorders and may act partly through lipid- and inflammation-related pathways, particularly HDL-C and neutrophil count.
    Keywords:  Brain; Cohort study; GDF15; Inflammation; Mendelian randomization
    DOI:  https://doi.org/10.1016/j.pnpbp.2026.111886
  9. J Food Sci. 2026 Aug;91(8): e71351
      Type 2 diabetes mellitus (T2DM) is a central component of the metabolic syndrome (MetS) and is associated with underlying mitochondrial dysfunction. Disruption of mitochondrial homeostasis impairs cellular energy metabolism and contributes to the overproduction of reactive oxygen species (ROS), leading to oxidative stress, chronic inflammation, and insulin resistance. These mitochondrial abnormalities exacerbate insulin resistance and impair pancreatic β-cell function, thereby accelerating the progression of T2D. Emerging evidence highlights the therapeutic potential of plant-derived biomolecules, particularly polyphenols found in traditional herbal teas, for mitigating oxidative stress and restoring mitochondrial integrity. This review explores the pathophysiological role of mitochondrial dysfunction and oxidative stress in T2D, with a focus on insulin action and β-cell function. We review three South African herbal teas (Rooibos, Honeybush, and Bush tea) and summarize how, through regulation of the oxidoreductase enzyme system, upregulation of endogenous antioxidant enzymes, inhibition of pro-oxidant enzymes, and support of mitochondrial biogenesis, demonstrating promising bioactivity. The review synthesizes current evidence on the herbal tea's key phytochemicals and their proposed mechanisms of action, highlighting their relevance in mitigating redox imbalance and preserving mitochondrial integrity within the context of diabetes. In addition, factors influencing their nutraceutical value, such as phytochemical composition, processing conditions, and bioavailability, are considered in relation to functional food development. By linking their antioxidant and anti-inflammatory properties to mitochondrial protection, this review underscores their potential role as complementary interventions in the management of T2D. Although emerging in vitro and in vivo studies suggest promising bioactivity of the herbal teas, the current evidence base remains limited by a lack of well-controlled human clinical trials.
    Keywords:  diabetes; herbal teas; mitochondrial dysfunction; oxidative stress
    DOI:  https://doi.org/10.1111/1750-3841.71351
  10. J Mol Cell Cardiol. 2026 Aug 11. pii: S0022-2828(26)00123-9. [Epub ahead of print]
      Heart failure with preserved ejection fraction (HFpEF) predominantly affects older women. The widely used two-hit model of HFpEF has mostly been applied to young animals and fails to induce HFpEF in female mice, limiting clinical and epidemiologic relevance. We challenged 19-month-old female mice with the two-hit protocol. Unlike young female mice, aged mice developed HFpEF, coinciding with impaired cardiac mitochondrial function and disrupted mitochondrial proteostasis. Our findings connect aging with increased female susceptibility to cardiometabolic stress and demonstrate the contribution of mitochondrial dysfunction in HFpEF. Incorporating aging to the two-hit model enables future investigation of sex-specific mechanisms of HFpEF.
    Keywords:  Aging; Cardiometabolic stress; Female sex; HFpEF; Mitochondrial complex II; Mitophagy; Proteostasis
    DOI:  https://doi.org/10.1016/j.yjmcc.2026.08.005
  11. Schizophr Bull Open. 2026 ;7(1): sgag029
       Background and Hypothesis: Mitochondrial dysfunction is increasingly implicated in schizophrenia (SZ) pathogenesis. To maintain mitochondrial homeostasis under cellular stress, a sophisticated mitochondrial quality control (MQC) mechanism has developed, encompassing mitochondrial biogenesis, dynamics, and mitophagy.
    Study Design: This study systematically evaluated MQC in peripheral leukocytes of 42 SZ patients and 43 healthy controls through morphological analysis, MQC gene expressions, mitochondrial DNA (mtDNA) maintenance, and oxidative damage. Besides, we validated the regulatory effects of oxidative stress on MQC in vitro using a neuronal model treated with hydrogen peroxide.
    Study Results: We observed mitochondrial fragmentation in SZ, characterized by increased organelle numbers with reduced sizes. This was supported by imbalanced MQC, with expression of biogenesis-related genes SIRT1 and TFAM upregulated (P = .008 and 0.027, respectively), and mitophagy receptor gene PHB2 suppressed (P = .041), indicating enhanced biogenesis but impaired mitophagy. Despite enhanced biogenesis, mtDNA copy number was lower (P < .001) with more oxidative damage (P = .037). Furthermore, we discovered deficits in antioxidant capacity, including reduced coenzyme Q10 levels and superoxide dismutase (SOD) activity, with SOD decline correlating with mtDNA depletion. This suggests redox imbalance contributes to MQC dysregulation, supported by findings from an oxidation-damaged neuronal model. Moreover, disrupted MQC functionally impaired energy metabolism, reflected by downregulated NDUFV1 expression (P = .031) and increased lactate-to-pyruvate ratios (P < .001).
    Conclusions: Our findings demonstrated MQC imbalance in SZ, manifested as mitochondrial fragmentation and mtDNA depletion, probably resulted from oxidative damage. These disruptions may underlie the energy metabolism abnormalities in SZ.
    Keywords:  mitochondrial biogenesis; mitochondrial dynamics; mitophagy; mtDNA copy number; oxidative stress
    DOI:  https://doi.org/10.1093/schizbullopen/sgag029
  12. J Neurochem. 2026 Aug;170(8): e70536
      The loss of ovarian hormones in postmenopause influences cognition, emotion and energy homeostasis, processes integrated by the hippocampus. The mechanisms by which estradiol influences this area have not been fully understood. The present study aimed at investigating the effects of estradiol on the rat hippocampus proteome of ovariectomy-induced menopause either followed by estradiol replacement or not. Eighteen 3-month-old female Wistar rats were either ovariectomized or sham operated and fed with standard chow for 3 months. A subgroup of ovariectomized rats received estradiol replacement. The hippocampi were processed using data independent acquisition MS-based proteomics and differentially expressed proteins were submitted to bioinformatics analysis for a pathway-based functional understanding of the estradiol effects. Proteomic analysis revealed that 49 hippocampal proteins were modulated by ovariectomy and estradiol replacement. Functional analysis of the differentially expressed proteins revealed the enrichment of terms related to energy metabolism (comprising glycolysis/gluconeogenesis, pyruvate metabolism, oxidative phosphorylation, and response to oxidative stress) and neuron projection (comprising cytoskeleton organization, regulation of vesicle-mediated transport, and modulation of chemical synaptic transmission). The present dataset indicates that, at the hippocampus, estradiol affects mitochondrial dynamics, lipid metabolism and intracellular trafficking machinery and influences dendritic and synaptic transmission and brain plasticity. Some alterations observed in proteins have not yet been described in the hippocampus in the context of menopause and estradiol replacement. These data provide new insights into the mechanisms involved with menopause effects and may help future studies related to drug development for the prevention and treatment of postmenopause associated symptoms.
    Keywords:  estrogen; menopause; metabolism; proteome
    DOI:  https://doi.org/10.1111/jnc.70536
  13. Sci Adv. 2026 Aug 14. 12(33): eaeh0657
      Mild mitochondrial stress could extend lifespan across species, yet the underlying mechanism remains unclear. Here, we show that inhibition of mitochondrial respiration induces a sustained transcriptional program that enhances lysosomal proteolysis during aging in Caenorhabditis elegans. Mechanistically, this response is primarily regulated by the intestinal GATA transcription factor ELT-2, which retains high expression and directly binds to GATA motifs in the promoters of lysosomal protease genes to promote their transcriptional activation. Moreover, we identified R249 within the conserved zinc-finger DNA binding domain of ELT-2 as a key residue required for its transcriptional activity. Notably, this mitochondrion-ELT-2-lysosome axis operates largely independently of the mitochondrial unfolded protein response (UPRmt) to counteract aging. Furthermore, increased lysosomal activity, as well as the lysosomal proteases CPR-5 and CPR-8, is essential for mitochondrial stress-induced clearance of toxic polyglutamine (polyQ) aggregates and lifespan extension. Together, our findings reveal a previously unrecognized ELT-2-dependent lysosomal proteostasis pathway that acts downstream of mitochondrial stress to maintain protein homeostasis and promote longevity.
    DOI:  https://doi.org/10.1126/sciadv.aeh0657
  14. Int J Mol Sci. 2026 Aug 01. pii: 6922. [Epub ahead of print]27(15):
      Caloric restriction (CR), defined as a 30-60% decrease in ad libitum food intake without malnutrition, has emerged as one of the most robust non-pharmacological interventions for promoting metabolic health and longevity in various species, including yeast, worms, flies, rodents, and perhaps non-human primates. In addition, CR has been shown to reduce the incidence of age-related disorders (for example, diabetes, cancer, and cardiovascular disorders) in mammals. Among the key organs influenced by CR, the pancreas-particularly the insulin-producing β-cells-plays a central role in maintaining glucose homeostasis and metabolic balance. A growing body of evidence suggests that CR exerts its beneficial effects, at least in part, through the modulation of nutrient-sensing pathways and epigenetic regulators. Sirtuins, a family of NAD+-dependent deacetylases and ADP-ribosyltransferases, have gained attention as pivotal molecular mediators of CR. By responding to changes in cellular energy status, sirtuins regulate diverse processes including gene expression, oxidative stress response, mitochondrial function, and autophagy. In the pancreas, sirtuins such as SIRT1, SIRT3, and SIRT6 have been implicated in preserving β-cell function, enhancing insulin secretion, and protecting against metabolic stress and inflammation. This review critically examines current evidence regarding the role of individual sirtuins in mediating the pancreatic response to caloric restriction, with particular emphasis on β-cell physiology, insulin secretion, mitochondrial function, autophagy, oxidative stress, and inflammatory signaling. We further discuss how these molecular mechanisms contribute to systemic metabolic homeostasis and may influence healthy longevity. Importantly, we integrate experimental findings with emerging clinical evidence demonstrating the recovery of β-cell function following dietary energy restriction and identify current controversies, limitations, and key knowledge gaps that should guide future translational research. Collectively, available evidence suggests that sirtuins represent central molecular links between caloric restriction and β-cell adaptation, highlighting their potential as therapeutic targets for preserving pancreatic function and preventing metabolic disease.
    Keywords:  aging; caloric restriction; insulin secretion; metabolic homeostasis; pancreatic β-cells; sirtuins
    DOI:  https://doi.org/10.3390/ijms27156922
  15. Neurochem Res. 2026 Aug 12. pii: 236. [Epub ahead of print]51(4):
      Oxidative stress, mitochondrial dysfunction, inflammation-associated cellular responses, and apoptosis are closely associated with the pathogenesis of neurodegenerative disorders. Therefore, identifying small molecules capable of modulating these interconnected cellular processes is important for the development of potential neuroprotective strategies. The present study investigated the protective effects of the imidazole derivative (IMD)-1 against hydrogen peroxide (H2O2)-induced oxidative injury in SH-SY5Y human neuroblastoma cells using integrated in vitro and in silico approaches. IMD-1 exhibited strong radical scavenging activity in the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, reaching 96.8% inhibition at 1000 µg/mL, which was comparable to the butylated hydroxyl toluene (BHT). IMD-1 pre-treatment significantly restored cell viability, reduced reactive oxygen species (ROS) production, and preserved mitochondrial membrane potential. IMD-1 also attenuated adenosine triphosphate (ATP) depletion. Moreover, IMD-1 reduced H2O2-induced increases in selected inflammation-associated mediators, including interleukin (IL)-2, IL-6, IL-12, vascular endothelial growth factor (VEGF), monocyte chemoattractant protein (MCP)-1, and interferon-gamma (IFN-γ). IMD-1 reduced apoptotic cell death and modulated apoptosis-related cellular and transcriptional responses. Molecular docking suggested a possible interaction between IMD-1 and caspase-8, providing hypothesis-generating support for the apoptosis-related findings. Overall, these findings suggest that IMD-1 attenuates H2O2-induced oxidative injury in SH-SY5Y cells as evidenced by changes in oxidative stress, mitochondrial dysfunction, ATP-associated bioenergetic impairment, inflammatory mediator release, and apoptosis-related responses. However, further protein-level, biochemical, and in vivo studies are required to determine the broader neurobiological and translational relevance of these findings.
    Keywords:  Apoptosis; Imidazole derivative; Mitochondrial dysfunction; Neuroprotection; Oxidative stress; SH-SY5Y cells
    DOI:  https://doi.org/10.1007/s11064-026-04861-0
  16. Free Radic Biol Med. 2026 Aug 11. pii: S0891-5849(26)01019-1. [Epub ahead of print]
      Imatinib (IMA), a front-line targeted therapy, was demonstrated by our prior study to potentially cause premature ovarian insufficiency (POI) after long-term administration. Additionally, we found that quercetin (QUE) may ameliorate IMA-induced ovarian injury by regulating mitophagy. Previous studies have shown that mitochondrial dysfunction may be involved in various cell death pathways. PANoptosis is a recently identified form of cell death that exhibits characteristics of pyroptosis, apoptosis, and necroptosis simultaneously. The present study further investigates whether IMA induces PANoptosis via mitochondrial dysfunction and explores the underlying mechanisms and potential therapeutic targets. In vitro experiments on granulosa cells revealed that IMA induced PANoptosis, characterized by membrane blebbing and swelling, pyknosis, as well as rupture of the nuclear and plasma membranes observed via transmission electron microscopy and confocal microscopy. This was accompanied by increased lactate dehydrogenase release, an elevated proportion of propidium iodide positive cells, and activation of caspase-3 (apoptosis), gasdermin D (GSDMD, pyroptosis), and mixed lineage kinase domain-like protein (MLKL, necroptosis). Network pharmacology revealed that the related genes associated with IMA, QUE, mitochondrial function, and POI were enriched in the MAPK pathway, with RAF1 identified as a key target. Western blot analysis demonstrated that IMA upregulated phosphorylation of RAF1, its downstream effector ERK1/2, and the mitochondrial fission mediator Drp1 (Ser616) in granulosa cells and ovarian. GW5074 (a RAF1 inhibitor), Mdivi1 (a Drp1 inhibitor), and QUE restored mitochondrial membrane potential and mitochondrial superoxide levels in granulosa cells and oocytes, suppressed IMA-induced PANoptosis, and improved granulosa cell viability and oocyte quality. These findings provide new insights into potential strategies for protecting ovarian function during IMA treatment.
    Keywords:  Imatinib; Mitochondrial function; PANoptosis; Premature ovarian insufficiency; Quercetin; RAF1-ERK1/2-Drp1 axis
    DOI:  https://doi.org/10.1016/j.freeradbiomed.2026.08.017
  17. Cell Metab. 2026 Aug 10. pii: S1550-4131(26)00281-0. [Epub ahead of print]
      Growth differentiation factor 15 (GDF15) is strongly associated with metabolic dysfunction-associated steatohepatitis (MASH), yet whether it promotes or protects against liver injury remains unclear. Using thermoneutral mouse models that closely resemble human MASH, genetic deletion of GDF15 or its receptor GFRAL selectively worsened hepatic inflammation and fibrosis without altering steatosis or insulin resistance. Conversely, recombinant GDF15 reduced liver inflammation and fibrosis more effectively than matched caloric restriction despite identical reductions in food intake, body weight, and steatosis, demonstrating weight-loss-independent hepatoprotection. These effects required GFRAL but were independent of β-adrenergic signaling. Instead, GDF15 activated the hypothalamic-pituitary-adrenal (HPA) axis, increasing circulating corticosterone and hepatic glucocorticoid receptor signaling. Spatial transcriptomics and RNA sequencing demonstrated that GDF15 remodeled the hepatic immune-fibrotic niche by suppressing inflammatory macrophages, plasma B cells, and activated stellate cells while promoting pro-resolving immune programs. Together, these findings identify a GDF15-GFRAL-HPA axis that restrains liver inflammation independently of weight loss.
    Keywords:  GFRAL; HPA; Kupffer cells; MASLD; RNA sequence; caloric restriction; glucocorticoid receptor; hypothalamic-pituitary-adrenal axis
    DOI:  https://doi.org/10.1016/j.cmet.2026.07.008
  18. Free Radic Biol Med. 2026 Aug 08. pii: S0891-5849(26)01010-5. [Epub ahead of print]255 774-790
      Oxidative stress and the progressive degeneration of dopaminergic neurons are key features of Parkinson's disease (PD). The intrinsically disordered structure of the transcription factor Nuclear factor erythroid 2-related factor 2 (Nrf2), which coordinates the main cellular antioxidant response of the body, makes it highly susceptible to misfolding and aggregation under severe oxidative stress, compromising cellular survival. Cannabidiol (CBD) has potent neuroprotective properties, but its exact molecular mechanism within the dopaminergic redox environment remains unclear. In this study, we investigated the protective effects of CBD against 6-hydroxydopamine (6-OHDA)-induced toxicity in both undifferentiated and mature, post-mitotic differentiated SH-SY5Y cells. We found that CBD confers robust Nrf2-dependent neuroprotection against 6-OHDA. Importantly, we uncover a previously unexplored mechanism of neuroprotection by which CBD actively prevents the stress-induced sequestration of Nrf2 into insoluble cytoplasmic inclusions under oxidative stress. We find that CBD keeps Nrf2 in a soluble, functional state, increases Ser40 phosphorylation, restores nuclear localization, and drives the robust transcriptional upregulation of antioxidant enzymes. This targeted activation of Nrf2 effectively reduces intracellular reactive oxygen species (ROS), significantly attenuates mitochondrial fragmentation, and decreases aberrant mitophagic activity. Overall, our results show that rather than merely scavenging reactive oxygen species, CBD directly increases Nrf2 activity during oxidative stress, enabling a sustained cytoprotective response. We thus identify CBD as a highly specific, targeted molecule with a high potential for neuroprotective therapy in PD.
    Keywords:  6-Hydroxydopamine; Cannabidiol; Mitochondrial dynamics; Neuroprotection; Nrf2; Parkinson's disease; Proteostasis
    DOI:  https://doi.org/10.1016/j.freeradbiomed.2026.08.012
  19. Exp Gerontol. 2026 Aug 10. pii: S0531-5565(26)00254-8. [Epub ahead of print]223 113275
      Dioscin, a naturally occurring steroidal saponin isolated from various kinds of herbs with pleiotropic pharmacological properties, remains mechanistically undefined regarding its mammalian aging modulation. This study discovered that dioscin extended the lifespan of Caenorhabditis elegans. Concurrently, dioscin improved the motor function of C. elegans and reduced age pigment accumulation, while having no effect on the reproductive performance of the C. elegans. By pathway screening, we identified that dioscin extends healthspan via the endoplasmic reticulum unfolded protein response (UPRER) transcription factor XBP-1. Moreover, lifespan assays conducted on nematode mutants that the UPRER key effectors (PERK, IRE1α and ATF6) demonstrated that dioscin influences the lifespan of C. elegans through all three of these key effectors. These findings provide a foundation for further investigation into its mechanism of action in regulating mammalian aging. In this study, we used naturally aged C57BL/6 J mice in a 6-month intervention study and found that dioscin significantly reduced expression of senescence markers (p21, p16) in hepatic and skeletal muscle tissues. Furthermore, dioscin maintains proteostasis through coordinated activation of the endoplasmic reticulum unfolded protein response (UPRER) key effectors (PERK, IRE1α, ATF6, and s-XBP1). Our study provides preclinical evidence supporting dioscin as a novel intervention that ameliorates aging-associated phenotypes and highlights the pivotal role of UPRER in lifespan extension and aging suppression.
    Keywords:  Aging; Caenorhabditis elegans; Dioscin; Lifespan; Mice; UPR(ER)
    DOI:  https://doi.org/10.1016/j.exger.2026.113275